The Beauty Health Company (SKIN)
SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored
Examine the evolution of SkinHealth Systems Inc.'s (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript
Beauty Health Q2 Earnings Call Highlights
Beauty Health NASDAQ: SKIN reported second-quarter revenue at the low end of its guidance range as cautious capital spending by providers continued to weigh on equipment sales, while stronger gross margins and expense discipline lifted adjusted EBITDA above expectations.
SkinHealth Systems Inc. (SKIN) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for SkinHealth Systems Inc. (SKIN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Earnings Preview: SkinHealth Systems Inc. (SKIN) Q2 Earnings Expected to Decline
SkinHealth Systems Inc. (SKIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SkinHealth Systems Inc. (SKIN) Upgraded to Strong Buy: Here's Why
SkinHealth Systems Inc. (SKIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention
Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beauty Health Q1 Earnings Call Highlights
Beauty Health NASDAQ: SKIN, referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year over year to $8.5 million, exceeding the high end of its guidance range.
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates
SkinHealth Systems Inc. (SKIN) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.08 per share a year ago.
Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics
The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
SkinHealth Systems Inc. (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
SkinHealth Systems Inc. (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
